Botanix Pharmaceuticals Limited

ASX (AUD): Botanix Pharmaceuticals Limited (BOT)

Last Price

0.325

Today's Change

-0.02 (5.79%)

Day's Change

0.32 - 0.35

Trading Volume

7,132,456

Overview

Market Cap

590 Million

Shares Outstanding

1 Billion

Avg Volume

5,993,430

Avg Price (50 Days)

0.38

Avg Price (200 Days)

0.29

PE Ratio

-32.50

EPS

-0.01

Earnings Announcement

27-Feb-2025

Previous Close

0.34

Open

0.35

Day's Range

0.32 - 0.35

Year Range

0.125 - 0.445

Trading Volume

7,132,456

Price Change Highlight

1 Day Change

-5.80%

5 Day Change

-9.72%

1 Month Change

-13.33%

3 Month Change

-12.16%

6 Month Change

44.44%

Ytd Change

71.05%

1 Year Change

160.00%

3 Year Change

415.87%

5 Year Change

35.42%

10 Year Change

712.50%

Max Change

-99.73%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Botanix Pharmaceuticals Limited engages in the research and development of dermatology and antimicrobial products in Australia. The company engages in development of novel treatments for common skin diseases and infections. Its product pipeline includes Sofpironium Bromide, a drug in development for the treatment of primary axillary hyperhidrosis that has completed Phase 3 clinical programs; BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers that has completed Phase II clinical trials; BTX 1801, which has completed Phase IIb clinical trials for the treatment of staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 that is in Phase IIb clinical trials for the treatment of papulopustular rosacea; and BTX 1204A for the treatment of atopic dermatitis. The company was incorporated in 1984 and is based in Leederville, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment